Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term Pregnancies

NCT ID: NCT00432588

Last Updated: 2007-06-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1/PHASE2

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypothesis (H0): Labor duration and obstetric complications are not significantly different in the three groups (misoprostol-dinoprostone-oxytocin).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preeclampsia Fetal Death Fetal Membranes, Premature Rupture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

misoprostol

Intervention Type DRUG

dinoprostone

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Term pregnancy
* Singleton
* Vertex
* Bishop score below 6

Exclusion Criteria

* History of drug reaction
* Medical disease
* IUGR
* Oligohydramnios
* Vaginal bleeding
* Fetal anomaly
* Uterine scar
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hormozgan University of Medical Sciences

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mitra Ahmad Soltani

Role: PRINCIPAL_INVESTIGATOR

Hormozgan University of Medical Sciences

Minoo Rajaee Lari, Perinatologist - Obs and Gyn

Role: STUDY_CHAIR

Department of Obs and Gyn - HUMS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shariaty Maternity Hospital

Tehran, , Iran

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Iran

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mitra Ahmad Soltani, MD

Role: primary

0098 021 22301004

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Misoprostol vs Dinoprostone

Identifier Type: -

Identifier Source: org_study_id